List of works - Lucy Mcnamara

CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.

scientific article published on 21 July 2017

Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.

scientific article

Ebola Surveillance - Guinea, Liberia, and Sierra Leone

scientific article published on 08 July 2016

HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.

scientific article

HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells

scientific article

Hematopoietic stem/precursor cells as HIV reservoirs.

scientific article

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

scientific article published on 14 July 2017

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

scientific article published in September 2017

Interferon Alfa Therapy: Toward an Improved Treatment for HIV Infection

article

Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis—Active Bacterial Core Surveillance Sites, 2011–2016

scientific article published on 15 April 2019

Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation.

scientific article

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.

scientific article published on 4 February 2017

Rapid Laboratory Identification of Neisseria meningitidis Serogroup C as the Cause of an Outbreak - Liberia, 2017.

scientific article published on 27 October 2017

Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.

scientific article

Safety of a meningococcal group B vaccine used in response to two university outbreaks

scientific article published on 8 May 2017

Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.

scientific article

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016

scientific article

The Epi Info Viral Hemorrhagic Fever (VHF) Application: A Resource for Outbreak Data Management and Contact Tracing in the 2014-2016 West Africa Ebola Epidemic

scientific article

The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.

scientific article

Towards a cure for HIV: the identification and characterization of HIV reservoirs in optimally treated people

article

Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013.

scientific article published in June 2014

Using Neisseria meningitidis genomic diversity to inform outbreak strain identification

scientific article published on 18 May 2021

Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis

scientific article

List of works by Lucy Mcnamara

CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.

Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.

Ebola Surveillance - Guinea, Liberia, and Sierra Leone

HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.

HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells

Hematopoietic stem/precursor cells as HIV reservoirs.

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

Interferon Alfa Therapy: Toward an Improved Treatment for HIV Infection

Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis—Active Bacterial Core Surveillance Sites, 2011–2016

Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation.

Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.

Rapid Laboratory Identification of Neisseria meningitidis Serogroup C as the Cause of an Outbreak - Liberia, 2017.

Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.

Safety of a meningococcal group B vaccine used in response to two university outbreaks

Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016

The Epi Info Viral Hemorrhagic Fever (VHF) Application: A Resource for Outbreak Data Management and Contact Tracing in the 2014-2016 West Africa Ebola Epidemic

The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.

Towards a cure for HIV: the identification and characterization of HIV reservoirs in optimally treated people

Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013.

Using Neisseria meningitidis genomic diversity to inform outbreak strain identification

Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis